Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Phosphorus Levels in Iron Deficient Children Treated with Ferric Carboxymaltose

Susan Kirk, PA-C, Donald Mahoney, MD, Melanie Brooke Bernhardt, PharmD, Jacquelyn M. Powers, MD,MSc

Blood (2019) 134 (Supplement_1): 2240.

https://doi.org/10.1182/blood-2019-129159

Published: 2019

Journal Articles

Study of Metabolic Acidosis in Sickle Cell Disease Patients

Maud Cazenave, MD, Vincent Audard, MDPhD, Jean-Philippe Bertocchio, MDPhD, Anoosha Habibi, Caroline Bertoye, MD, Thomas Stehle, MD, Jugurtha Berkenou, Frédéric Galactéros, MD PhD, Pascal Houillier, Pablo Bartolucci, MD PhD, Marie Courbebaisse, MD PhD

Blood (2018) 132 (Supplement 1): 3667.

https://doi.org/10.1182/blood-2018-99-110235

Published: 2018

Journal Articles

Incidence and Predictors of Adverse Respiratory Events during Induction Therapy in Children with Acute Myeloid Leukemia

Lane Miller, MD, Sharon M. Castellino, MD MSc, Ann Mertens, PhD, Frank G Keller, MD, William G Woods, MD

Blood (2017) 130 (Supplement 1): 2590.

https://doi.org/10.1182/blood.V130.Suppl_1.2590.2590

Published: 2017

Journal Articles

Evaluation of Risk Factors and Survival Effect of Delayed Excretion of High-Dose Methotrexate in Patients with Leukemia and Lymphoma

Kentaro Narita, MD, Hiroki Kobayashi, MD, Yoshiaki Abe, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2017) 130 (Supplement 1): 4132.

https://doi.org/10.1182/blood.V130.Suppl_1.4132.4132

Published: 2017

Journal Articles

Phase I Trial of Targeted Alpha-Particle Therapy with Actinium-225 ( 225 Ac)-Lintuzumab and Low-Dose Cytarabine (LDAC) in Patients Age 60 or Older with Untreated Acute Myeloid Leukemia (AML)

Joseph G. Jurcic, MD, Moshe Yair Levy, MD, Jae H. Park, MD, Farhad Ravandi, MD, Alexander E. Perl, MD, John M. Pagel, MD PhD, B. Douglas Smith, MD, Elihu H. Estey, MD, Hagop Kantarjian, MD, Dragan Cicic, MD, David A. Scheinberg, MD PhD

Blood (2016) 128 (22): 4050.

https://doi.org/10.1182/blood.V128.22.4050.4050

Published: 2016

Journal Articles

Distinct Immunogenetic Signatures in IgA Versus IgG Multiple Myeloma

Katerina Gemenetzi, Andreas Agathangelidis, Apostolia Papalexandri, Alejandro Medina, Elisa Genuardi, Theodoros Moysiadis, Evdoxia Hatjiharissi, Maria Papaioannou, Evangelos Terpos, Cristina Jimenez, Chrysavgi Lalayanni, Achilles Anagnostopoulos, Simone Ferrero, Marco Ladetto, MD, Ramon Garcia Sanz, Chrysoula Belessi, Anastasia Hadzidimitriou, Kostas Stamatopoulos, MD PhD

Blood (2016) 128 (22): 2062.

https://doi.org/10.1182/blood.V128.22.2062.2062

Published: 2016

Journal Articles

Arsenic Trioxide As a Front-Line Therapy for Newly Diagnosed Acute Promyelocytic Leukemia

Weihong Chen, MD, Xin Du, MD, Jiacai Zhuo, MD

Blood (2015) 126 (23): 4937.

https://doi.org/10.1182/blood.V126.23.4937.4937

Published: 2015

Journal Articles

Characteristics of "Older Old" Patients with Sickle Cell Anemia Who Survived for More Than 80 Years

Dianne Pulte, MD, Gaye Riddick-Burden, MSN, Samir K. Ballas, MD

Blood (2015) 126 (23): 4599.

https://doi.org/10.1182/blood.V126.23.4599.4599

Published: 2015

Journal Articles

Phase I Trial of Targeted Alpha-Particle Immunotherapy with Actinium-225 ( 225 Ac)-Lintuzumab (Anti-CD33) and Low-Dose Cytarabine (LDAC) in Older Patients with Untreated Acute Myeloid Leukemia (AML)

Joseph G. Jurcic, MD, Farhad Ravandi, MD, John M. Pagel, MD PhD, Jae H. Park, MD, B. Douglas Smith, MD, Moshe Yair Levy, MD, Elihu H. Estey, MD, Alexander E. Perl, MD, Hagop Kantarjian, MD, Dennis Earle, Dragan Cicic, MD, David A. Scheinberg, MD PhD

Blood (2015) 126 (23): 3794.

https://doi.org/10.1182/blood.V126.23.3794.3794

Published: 2015

Journal Articles

Pregnancy-Associated Atypical Hemolytic Uremic Syndrome (aHUS), Treated with Eculizumab

Eudokia M. Mandala, Associate Professor, Spyridon Gkiouzepas, MD, Efstratios Kasimatis, MD, Christos Lafaras, MD PhD, Parthenis Chalevas, MD, Konstantina Tsioni, MD PhD, Krystallia Kyrka, MD, Dominiki Oikonomidou, MD PhD, Konstantinos Dinas, Assistant Professor, Aristotelis Loufopoulos, Professor, George Efstratiadis, Professor, Garipidou Vasilia, Professor, Anastasios-Alexandros Garyfallos, Professor

Blood (2014) 124 (21): 5019.

https://doi.org/10.1182/blood.V124.21.5019.5019

Published: 2014

Journal Articles

Phase I Trial of Targeted Alpha-Particle Therapy Using Actinium-225 ( 225 Ac)-Lintuzumab (Anti-CD33) in Combination with Low-Dose Cytarabine (LDAC) for Older Patients with Untreated Acute Myeloid Leukemia (AML)

Joseph G Jurcic, MD, Farhad Ravandi, MD, John M. Pagel, MD PhD, Jae H Park, MD, B. Douglas Smith, MD, Dan Douer, MD, Elihu H. Estey, MD, Hagop M. Kantarjian, MD, Richard L. Wahl, MD, Dennis Earle, Dragan Cicic, MD, David A. Scheinberg, MD PhD

Blood (2014) 124 (21): 5293.

https://doi.org/10.1182/blood.V124.21.5293.5293

Published: 2014

Journal Articles

Next Generation Sequencing of B Cell Antigen Receptors Expressed in African Endemic Burkitt Lymphoma

Katharine Lombardo, Andrea M. H. Towlerton, Alicia Morales, Sarah Gerdts, MPH, Innocent Mutyaba, MD, Abrahams Omoding, MD, Jackson Orem, MD, Erica Sessle, MPH, Corey Casper, MD, Edus Warren, MD PhD

Blood (2014) 124 (21): 1687.

https://doi.org/10.1182/blood.V124.21.1687.1687

Published: 2014

Journal Articles

Plerixafor and G-CSF For Autologous Stem Cell Mobilization In AL Amyloidosis: A Single Center Experience

Esha Kaul, MD, Gunjan L Shah, MD MS, Chakra P Chaulagain, MD, FACP, Raymond L. Comenzo, MD

Blood (2013) 122 (21): 4516.

https://doi.org/10.1182/blood.V122.21.4516.4516

Published: 2013

Journal Articles

Ongoing Antigen Interactions In Splenic Marginal Zone Lymphoma: Revelations From The Analysis Of Intraclonal Diversification In Immunoglobulin Light Chain Genes

Maria Karypidou, Evangelia Stalika, Panagiotis Baliakas, Vasilis Bikos, Zadie Davis, George Kanellis, Achilles Anagnostopoulos, MD, Theodora Papadaki, David Oscier, Anastasia Hadzidimitriou, Nikos Darzentas, Chrysoula Belessi, Kostas Stamatopoulos

Blood (2013) 122 (21): 2999.

https://doi.org/10.1182/blood.V122.21.2999.2999

Published: 2013

Journal Articles

Heart MRI Identifies Patients At Higher Risk For Severe Pulmonary Edema After Bortezomib Plus Dexamethasone Treatment In Subclinical Heart Amyloidosis

Matthew Zheng, Gustavo A. Rivero, MD

Blood (2013) 122 (21): 5330.

https://doi.org/10.1182/blood.V122.21.5330.5330

Published: 2013

Journal Articles

Drug Metabolites Formed in Vivo Promote the Clearance of Human Platelets by Metabolite-Dependent Antibodies in NOD/SCID Mice

Daniel W. Bougie, PhD, Dhirendra Nayak, Richard H. Aster, MD

Blood (2012) 120 (21): 1083.

https://doi.org/10.1182/blood.V120.21.1083.1083

Published: 2012

Journal Articles

Effectiveness of Defibrotide in the Prevention of VOD Among Patients Receiving Allogeneic Hematopoetic Cell Transplantation: A Retrospective Single Center Experience

Emre Tekgunduz, MD, Seval Akpinar, Sinem Civriz Bozdag, MD, Aysegul Tetik, Serife Kocubaba, Murat Cinarsoy, Gamze Durgun, Sinem Namdaroglu, Omür Kayikci, Bilge Ugur, Itir Sirinoglu Demiriz, Fevzi Altuntas, MD

Blood (2012) 120 (21): 4508.

https://doi.org/10.1182/blood.V120.21.4508.4508

Published: 2012

Journal Articles

Chronic Lymphocytic Leukemia Patients with IGHV Genes Carrying Only Silent Mutations Have A Longer Time From Diagnosis to Initial Therapy Than Patients Expressing B-Cell Receptors with No Somatic Mutations

Matthew Kaufman, MD, Xiao J. Yan, MD, PhD, Emanuela M. Ghia, PhD, Donna Neuberg, ScD, Laura Z. Rassenti, Ph.D., Kostas Stamatopoulos, MD, Paolo Ghia, MD, PhD, David G Oscier, MD, Frederic Davi, MD, PhD, Richard Rosenquist, MD, PhD, Chrysoula Belessi, MD, Zadie Davis, PhD, Andreas Agathangelidis, Neil Kay, MD, John C. Byrd, MD, Jennifer R Brown, MD, PhD, Kanti R. Rai, M.D., Thomas J. Kipps, M.D., Ph.D, Nicholas Chiorazzi, M.D.

Blood (2011) 118 (21): 288.

https://doi.org/10.1182/blood.V118.21.288.288

Published: 2011

Journal Articles

Primary Intraocular Lymphomas Display A Remarkably Biased Immunoglobulin Heavy Chain Gene Repertoire and Precisely Targeted Somatic Hypermutation Suggesting Antigenic Selection of the Neoplastic Cells

Nabila Belhouachi, Evangelia Stalika, Bahram Bodaghi, Myriam Boudjoghra, Nathalie Cassoux, Christine Fardeau, Sylvie Baudet, Phuc Le Hoang, Helene Merle-Beral, Kostas Stamatopoulos, MD, Frederic Davi

Blood (2011) 118 (21): 1574.

https://doi.org/10.1182/blood.V118.21.1574.1574

Published: 2011

Journal Articles

Improved Outcome of CLL Patients with Leukemic Clones Expressing Mutated IGHV May Not Be Due to An Inability to Bind (auto)Antigen In Vivo

Matthew Kaufman, Xiao-Jie Yan, M.D.;, Ph.D., Emanuela M. Ghia, PhD, Donna Neuberg, ScD, Laura Z Rassenti, PhD, Jennifer R Brown, MD, PhD, John C. Byrd, MD, Neil E. Kay, Kanti R Rai, MD, Thomas J. Kipps, MD, PhD, Nicholas Chiorazzi

Blood (2010) 116 (21): 2441.

https://doi.org/10.1182/blood.V116.21.2441.2441

Published: 2010

NARROW

Phosphorus Levels in Iron Deficient Children Treated with Ferric Carboxymaltose

Study of Metabolic Acidosis in Sickle Cell Disease Patients

Incidence and Predictors of Adverse Respiratory Events during Induction Therapy in Children with Acute Myeloid Leukemia

Evaluation of Risk Factors and Survival Effect of Delayed Excretion of High-Dose Methotrexate in Patients with Leukemia and Lymphoma

Phase I Trial of Targeted Alpha-Particle Therapy with Actinium-225 ( 225 Ac)-Lintuzumab and Low-Dose Cytarabine (LDAC) in Patients Age 60 or Older with Untreated Acute Myeloid Leukemia (AML)

Distinct Immunogenetic Signatures in IgA Versus IgG Multiple Myeloma

Arsenic Trioxide As a Front-Line Therapy for Newly Diagnosed Acute Promyelocytic Leukemia

Characteristics of "Older Old" Patients with Sickle Cell Anemia Who Survived for More Than 80 Years

Phase I Trial of Targeted Alpha-Particle Immunotherapy with Actinium-225 ( 225 Ac)-Lintuzumab (Anti-CD33) and Low-Dose Cytarabine (LDAC) in Older Patients with Untreated Acute Myeloid Leukemia (AML)

Pregnancy-Associated Atypical Hemolytic Uremic Syndrome (aHUS), Treated with Eculizumab

Phase I Trial of Targeted Alpha-Particle Therapy Using Actinium-225 ( 225 Ac)-Lintuzumab (Anti-CD33) in Combination with Low-Dose Cytarabine (LDAC) for Older Patients with Untreated Acute Myeloid Leukemia (AML)

Next Generation Sequencing of B Cell Antigen Receptors Expressed in African Endemic Burkitt Lymphoma

Plerixafor and G-CSF For Autologous Stem Cell Mobilization In AL Amyloidosis: A Single Center Experience

Ongoing Antigen Interactions In Splenic Marginal Zone Lymphoma: Revelations From The Analysis Of Intraclonal Diversification In Immunoglobulin Light Chain Genes

Heart MRI Identifies Patients At Higher Risk For Severe Pulmonary Edema After Bortezomib Plus Dexamethasone Treatment In Subclinical Heart Amyloidosis

Drug Metabolites Formed in Vivo Promote the Clearance of Human Platelets by Metabolite-Dependent Antibodies in NOD/SCID Mice

Effectiveness of Defibrotide in the Prevention of VOD Among Patients Receiving Allogeneic Hematopoetic Cell Transplantation: A Retrospective Single Center Experience

Chronic Lymphocytic Leukemia Patients with IGHV Genes Carrying Only Silent Mutations Have A Longer Time From Diagnosis to Initial Therapy Than Patients Expressing B-Cell Receptors with No Somatic Mutations

Primary Intraocular Lymphomas Display A Remarkably Biased Immunoglobulin Heavy Chain Gene Repertoire and Precisely Targeted Somatic Hypermutation Suggesting Antigenic Selection of the Neoplastic Cells

Improved Outcome of CLL Patients with Leukemic Clones Expressing Mutated IGHV May Not Be Due to An Inability to Bind (auto)Antigen In Vivo

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only